Eterna Therapeutics OverviewEterna Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ERNA.
Quarterly EBIT
-$3.55M
↓ 29.89% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$9.34M
↑ 24.85% YoY
Trailing 12 months ending Mar 31, 2026
Eterna Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for ERNA.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026